Arcellx (ACLX) Capital Expenditures (2021 - 2025)

Arcellx's (ACLX) quarterly Capital Expenditures came in at $1.8 million in Q4 2025, down 84.89% year-on-year from $12.1 million in Q4 2024, and up 671.31% quarter-over-quarter from $237000.0 in Q3 2025.

Arcellx (ACLX) Capital Expenditures (2021 - 2025) Analysis & Trends

Arcellx's Capital Expenditures history runs 5 years deep, the most recent figure standing at $1.8 million for Q4 2025.

  • On a quarterly basis, Capital Expenditures fell 84.89% year-over-year to $1.8 million in Q4 2025; TTM through Dec 2025 was $2.3 million, a 82.68% decrease from a year earlier, with the FY2025 full-year figure at $2.3 million, down 82.68% from the prior year.
  • Capital Expenditures climbed to $1.8 million in Q4 2025 per ACLX's latest filing, from $237000.0 in the prior quarter.
  • Across five years, Capital Expenditures topped out at $14.2 million in Q4 2023 and bottomed at -$8.3 million in Q3 2024.
  • The 5-year median for Capital Expenditures is $623500.0 (2022), against an average of $2.2 million.
  • Across the five-year window, Capital Expenditures surged 4751.01% in 2023 and sank 729.44% in 2024, its largest moves.
  • Year by year, Capital Expenditures stood at $4.8 million in 2021, then sank by 92.85% to $340000.0 in 2022, then jumped by 4082.94% to $14.2 million in 2023, then fell by 14.92% to $12.1 million in 2024, then tumbled by 84.89% to $1.8 million in 2025.
  • Per Business Quant, the three latest ACLX Capital Expenditures figures stand at $1.8 million (Q4 2025), $237000.0 (Q3 2025), and -$518000.0 (Q2 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Capital Expenditures (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - -8,939.03
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 43.25 Mn
4 NuCana 279.75 Bn 279.75 Bn - -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn 133.40 Mn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn 230.60 Mn
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn -
9 Revolution Medicines 37.78 Bn 37.78 Bn - 786,000.00
10 Arcellx 6.48 Bn 6.48 Bn - 1.83 Mn

Historic Data

Download Data
DateValue
Dec 31, 2025 1.83 Mn
Dec 31, 2025 1.83 Mn
Sep 30, 2025 237,000.00
Sep 30, 2025 237,000.00
Jun 30, 2025 -518,000.00
Jun 30, 2025 -518,000.00
Mar 31, 2025 780,000.00
Mar 31, 2025 780,000.00
Dec 31, 2024 12.10 Mn
Dec 31, 2024 12.10 Mn
Sep 30, 2024 -8.31 Mn
Sep 30, 2024 -8.31 Mn
Jun 30, 2024 3.21 Mn
Jun 30, 2024 3.21 Mn
Mar 31, 2024 6.43 Mn
Mar 31, 2024 6.43 Mn
Dec 31, 2023 14.22 Mn
Dec 31, 2023 14.22 Mn
Sep 30, 2023 -1.00 Mn
Sep 30, 2023 -1.00 Mn